Yukiko Kiniwa and Cancer - Free people check

(1 - 11 from 13

)

Cancer vaccine work continues at Baylor - Mongabaynews.mongabay.com › › cancer-vaccine-work-continues-at-baylor

news.mongabay.com

Aug 26, · Others who participated in this research include: Drs. Guangyong Peng, Yukiko Kiniwa, Kui shin Voo, Tihui Fu, and Yanchun Li; and Zhong ...

Improving The Potential Of Cancer Vaccines -- ScienceDaily

www.sciencedaily.com

Others who participated in this research include: Drs. Guangyong Peng, Yukiko Kiniwa, Kui shin Voo, Tihui Fu, and Yanchun Li; and Zhong Guo, Weiyi Peng,

Erica Pranzini | 13 Publications | 97 Citations | Related Authors

typeset.io

Yukiko Kiniwa 1•Institutions (1). 31 Mar Gan to kagaku ryoho. Cancer & chemotherapy citations. Journal Article•. › authors

Cancer Immunotherapy: Immune Suppression and Tumor Growth

books.google.co.uk

Wang, H. Y., Deen A. Lee, Guangyong Peng, Zhong Guo, Yanchun Li, Yukiko Kiniwa, Shevach, E. M., and Wang, R.-F. (2004). Tumor-specific human CD4+ regulatory ...

Cancer Immunotherapy: Immune Suppression and Tumor Growth - Google...

books.google.ch

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights...

Mixed Response to Cancer Immunotherapy is Driven by ...

aacrjournals.org

by T Morinaga · · Cited by 1 — Yukiko Kiniwa. ORCID logo ;. Yukiko Kiniwa. 12Department of Dermatology, Shinshu University School of Medicine, Nagano, Japan. › article-abstract

Yukiko Kiniwa's Research | CureHunter

www.curehunter.com

Yukiko Kiniwa Selected Research. Yukiko Kiniwa Research Neoplasms (Cancer) Melanoma (Melanoma, Malignant)

muscle invasive bladder cancer treated with intravesical therapy.

iqjmc.net

yukiko kiniwa , makoto tsukamoto: Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer) Int. J. Cancer: 108, 712–724 (2004) Pavoni E, Monteriu G, Santapaola D et al: Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins.